{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2024:XD6BASOMMQ62L5TINCWSBL4TWU","short_pith_number":"pith:XD6BASOM","schema_version":"1.0","canonical_sha256":"b8fc1049cc643da5f66868ad20af93b51afb5f976b926f478c11743d246b52c1","source":{"kind":"arxiv","id":"2405.10871","version":1},"attestation_state":"computed","paper":{"title":"BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"cs.CV","authors_text":"Alexandros Karargyris, Bhakti Baheti, Calixto-Hope G. Lucas, Giselle Y. L\\'opez, Hasan Kassem, Jake Albrecht, Jared T. Ahrendsen, Jason T. Huse, Lee A. D. Cooper, MacLean P. Nasrallah, Mana Moassefi, Maria A. Gubbiotti, Michael L. Miller, Sarthak Pati, Shahriar Faghani, Shubham Innani, Siddhesh P. Thakur, Spyridon Bakas, Ujjwal Baid, Valeria Barresi, Verena Chung, William R. Bell","submitted_at":"2024-05-17T16:02:21Z","abstract_excerpt":"Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is widely infiltrative in the cerebral hemispheres and well-defined by heterogeneous molecular and micro-environmental histopathologic profiles, which pose a major obstacle in treatment. Correctly diagnosing these tumors and assessing their heterogeneity is crucial for choosing the precise treatment and potentially enhancing patient survival rates. In the gold-standard histopathology-based approach to tumor diagnosis, detec"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2405.10871","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"cs.CV","submitted_at":"2024-05-17T16:02:21Z","cross_cats_sorted":[],"title_canon_sha256":"462f186e54e08190cfe2d6409b33500511433f4ccf7a39454b4c71a4a4ed70c7","abstract_canon_sha256":"b68223487d2e9dfe5045ff583588b703fd94be727f870023f9ec3245ad0d25fc"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T08:20:18.228356Z","signature_b64":"Vu5D5ybBjM5Z5cdw7qhwvzmm9ilz6NOxdAbdOuc4Y/miA2WaQb2XDK1lcAJIn9JGZZyU+siQi4dmNO+SRTzaAA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"b8fc1049cc643da5f66868ad20af93b51afb5f976b926f478c11743d246b52c1","last_reissued_at":"2026-07-05T08:20:18.227949Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T08:20:18.227949Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"cs.CV","authors_text":"Alexandros Karargyris, Bhakti Baheti, Calixto-Hope G. Lucas, Giselle Y. L\\'opez, Hasan Kassem, Jake Albrecht, Jared T. Ahrendsen, Jason T. Huse, Lee A. D. Cooper, MacLean P. Nasrallah, Mana Moassefi, Maria A. Gubbiotti, Michael L. Miller, Sarthak Pati, Shahriar Faghani, Shubham Innani, Siddhesh P. Thakur, Spyridon Bakas, Ujjwal Baid, Valeria Barresi, Verena Chung, William R. Bell","submitted_at":"2024-05-17T16:02:21Z","abstract_excerpt":"Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is widely infiltrative in the cerebral hemispheres and well-defined by heterogeneous molecular and micro-environmental histopathologic profiles, which pose a major obstacle in treatment. Correctly diagnosing these tumors and assessing their heterogeneity is crucial for choosing the precise treatment and potentially enhancing patient survival rates. In the gold-standard histopathology-based approach to tumor diagnosis, detec"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2405.10871","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2405.10871/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2405.10871","created_at":"2026-07-05T08:20:18.228007+00:00"},{"alias_kind":"arxiv_version","alias_value":"2405.10871v1","created_at":"2026-07-05T08:20:18.228007+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2405.10871","created_at":"2026-07-05T08:20:18.228007+00:00"},{"alias_kind":"pith_short_12","alias_value":"XD6BASOMMQ62","created_at":"2026-07-05T08:20:18.228007+00:00"},{"alias_kind":"pith_short_16","alias_value":"XD6BASOMMQ62L5TI","created_at":"2026-07-05T08:20:18.228007+00:00"},{"alias_kind":"pith_short_8","alias_value":"XD6BASOM","created_at":"2026-07-05T08:20:18.228007+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/XD6BASOMMQ62L5TINCWSBL4TWU","json":"https://pith.science/pith/XD6BASOMMQ62L5TINCWSBL4TWU.json","graph_json":"https://pith.science/api/pith-number/XD6BASOMMQ62L5TINCWSBL4TWU/graph.json","events_json":"https://pith.science/api/pith-number/XD6BASOMMQ62L5TINCWSBL4TWU/events.json","paper":"https://pith.science/paper/XD6BASOM"},"agent_actions":{"view_html":"https://pith.science/pith/XD6BASOMMQ62L5TINCWSBL4TWU","download_json":"https://pith.science/pith/XD6BASOMMQ62L5TINCWSBL4TWU.json","view_paper":"https://pith.science/paper/XD6BASOM","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2405.10871&json=true","fetch_graph":"https://pith.science/api/pith-number/XD6BASOMMQ62L5TINCWSBL4TWU/graph.json","fetch_events":"https://pith.science/api/pith-number/XD6BASOMMQ62L5TINCWSBL4TWU/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/XD6BASOMMQ62L5TINCWSBL4TWU/action/timestamp_anchor","attest_storage":"https://pith.science/pith/XD6BASOMMQ62L5TINCWSBL4TWU/action/storage_attestation","attest_author":"https://pith.science/pith/XD6BASOMMQ62L5TINCWSBL4TWU/action/author_attestation","sign_citation":"https://pith.science/pith/XD6BASOMMQ62L5TINCWSBL4TWU/action/citation_signature","submit_replication":"https://pith.science/pith/XD6BASOMMQ62L5TINCWSBL4TWU/action/replication_record"}},"created_at":"2026-07-05T08:20:18.228007+00:00","updated_at":"2026-07-05T08:20:18.228007+00:00"}